文献速递腹部泌尿生殖MR

肾脏黏液性管状和梭形细胞癌的MR特征:与透明细胞及乳头状肾细胞癌亚型的比较

MR characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: comparison with clear cell and papillary subtypes of renal cell carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2021-08-02

该回顾性研究纳入15例MTSCC、30例ccRCC和30例pRCC,评估T2信号比值和动态增强各期强化比。MTSCC的T2比值介于ccRCC与pRCC之间且与两者无显著差异;MTSCC强化程度显著高于pRCC,呈渐进性强化,可与pRCC鉴别。

要点

  • MTSCC的T2信号比值(1.02)介于ccRCC(1.24)与pRCC(0.84)之间,与两者均无统计学差异。
  • MTSCC在皮髓质期、肾实质期和排泄期的强化比均显著高于pRCC,呈渐进性强化模式。
  • 早期结节状强化在MTSCC中占36%(4/11),ccRCC中占57%,pRCC中仅7%,非特异但可提示诊断。

关键影像表现/征象

  • T2比值(病灶与肾皮质信号强度比)均值:ccRCC 1.24、MTSCC 1.02、pRCC 0.84。
  • ccRCC与pRCC的T2比值差异显著(p < 0.001),MTSCC与ccRCC(p = 0.4)或pRCC(p = 0.2)无显著差异。
  • 强化比均值:皮髓质期MTSCC 1.33、ccRCC 1.53、pRCC 0.38;肾实质期1.60、1.61、0.69;排泄期1.79、1.35、0.77。
  • MTSCC与pRCC的强化比在皮髓质期(p = 0.01)、肾实质期(p = 0.003)和排泄期(p = 0.002)均差异显著。
  • 早期结节状强化发生率:MTSCC 4/11(36%)、ccRCC 17/30(57%)、pRCC 2/30(7%)。

诊断标准与关键数值

  • T2比值 = 病灶信号强度 / 肾皮质信号强度(T2WI无脂肪抑制)。
  • 强化比 = (增强后信号强度 - 增强前信号强度) / 增强前信号强度,基于整个病灶在各期DCE图像上的信号强度。
  • 早期结节状强化为主观评估指标,无量化阈值。

临床应用与阅片要点

  • 在肾脏实性肿瘤鉴别中,若T2信号中等且动态增强呈渐进性强化(各期强化比均高于pRCC),应想到MTSCC可能。
  • MTSCC与ccRCC的T2比值和强化比有重叠,单凭MR难以完全区分,需结合其他征象。
  • 早期结节状强化在MTSCC中可见但非特异,ccRCC更常见,pRCC少见。

局限性

  • 回顾性研究,样本量小(MTSCC仅15例,DCE仅11例)。
  • 单中心设计,可能存在选择偏倚。
  • 早期结节状强化为主观评估,缺乏量化标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To describe MR features of mucinous tubular spindle cell carcinoma (MTSCC) of the kidney that may help differentiate from clear cell renal cell carcinoma (ccRCC) and papillary RCC (pRCC).

METHODS: 15 MTSCCs were retrospectively evaluated by MR with T2-weighted image without fat suppression (n = 15) and dynamic contrast-enhanced (DCE), fat-suppressed T1-weighted GRE (n = 11). Size-matched ccRCC (n = 30) and pRCC (n = 30) were evaluated as control. T2 ratio was calculated as the signal intensity (SI) ratio of the lesion to the renal cortex on T2W images. Enhancement ratio (ER) was calculated as (SIpost - SIpre)/(SIpre), where SIpre (SIpost) is the SI of the entire lesion on each phase of DCE images. Early nodular enhancement was subjectively evaluated in MTSCC. T2 ratio and ER were compared using the Mann-Whitney U test with Bonferroni correction.

RESULTS: The mean value of T2 ratio was highest in ccRCC (1.24), followed by MTSCC (1.02), and pRCC (0.84). Difference of T2 ratio was significant between ccRCC and pRCC (p < 0.001), but not between MTSCC and ccRCC (p = 0.4) or between MTSCC and pRCC (p = 0.2). The mean ER of MTSCC, ccRCC and pRCC were 1.33, 1.53 and 0.38 in corticomedullary phase (CMP), 1.60, 1.61 and 0.69 in nephrographic phase (NGP) and 1.79, 1.35 and 0.77 in excretory phase (EP), respectively. ERs were significantly different between MTSCC and pRCC in CMP (p = 0.01), NGP (p = 0.003), and EP (p = 0.002). Early nodular enhancement was observed in 4/11 MTSCC (36%), 17/30 ccRCC (57%), and 2/30 pRCC (7%).

CONCLUSIONS: MTSCC has distinct MR features that can help differentiate from ccRCC and pRCC. MTSCC enhances more avidly compared to pRCC and shows gradual progressive enhancement.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Takahashi H, Vikram R, Jimenez RE, et al. MR characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: comparison with clear cell and papillary subtypes of renal cell carcinoma. Abdom Radiol (NY). 2021. PMID: 34338814. doi:10.1007/s00261-021-03227-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。